Easy-to-use genome analyser offered

Tuesday, 14 June, 2011

Scientists at Albert Einstein College of Medicine of Yeshiva University have developed a desktop genome analyser and browser that allows biologists to rapidly and easily analyse and process their high-throughput data. The open-source software, called GenPlay, is described in the 19 May online edition of Bioinformatics.

Currently, genomic data is analysed mainly by information specialists rather than by the biologists who designed the experiments that produce the data. GenPlay was created with the goal of offering biologists a user-friendly, multipurpose tool that can help them visualise, analyse and transform their raw data into biologically relevant tracks.

“The first human genome was sequenced 10 years ago by an international consortium at a cost of $7 billion,” notes GenPlay co-developer Eric Bouhassira, PhD, senior author of the Bioinformatics article, professor of medicine and of cell biology, and the Ingeborg and Ira Leon Rennert Professor of Stem Cell Biology and Regenerative Medicine at Einstein. “But today, a complete genome can be sequenced for less than $10,000 and the cost is predicted to drop to less than $1000 in a few years. The dramatic dip in cost has led to the creation of an avalanche of new data that biologists are having trouble analysing. GenPlay is intended to make it easier for biologists to make sense of their data.”

A dozen or so genome browsers are currently available. GenPlay offers a major advantage over the others, says Dr Bouhassira, because it “emphasises letting biologists take control of their own data by providing continuous visual feedback together with extremely rapid browsing at every decision point during an analysis”.

GenPlay handles three major types of data: data from gene expression studies, epigenetic data and single nucleotide polymorphism (SNP) data.

The GenPlay software is available from http://www.genplay.net.

Related News

Blood-based biomarker can detect sleep deprivation

The biomarker detected whether individuals had been awake for 24 hours with a 99.2% probability...

Epigenetic signature helps to diagnose rare breast tumour

The current way of diagnosing phyllodes tumours is to analyse their cellular features under a...

New instrument measures cardiovascular disease biomarkers

CVD-21 enables a 'liquid cardiovascular biopsy' for quantification of multiple...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd